white/saratani

Kiungo kimehifadhiwa kwenye clipboard

Chagua aina ya aina

11 matokeo

Phorbol esters as anti-neoplastic and white blood cell elevating agents

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BRIEF DESCRIPTION OF THE INVENTION The invention relates to treating neoplastic disease such as leukemia and increasing the white blood cell counts in patients suffering from neoplastic diseases or undergoing chemotherapy by a method which comprises administering parenterally to patients an

Composition comprising egg white combined chalcanthite for preventing or treating cancer

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

CROSS-REFERENCE TO RELATED APPLICATION The application claims the benefit under 35 U.S.C. .sctn.119 of Korean Patent Application No. 10-2008-0136873, filed Dec. 30, 2008, which is hereby incorporated by reference in its entirety. FIELD OF THE INVENTION The present invention relates to a composition

Synthesis and uses of new ascorbic acid derivatives which have anti-oxidant and anti-cancer activities

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to new hydrophobic ascorbic ester compounds, which are synthesized by linking ascorbic acid either wit monomer prostaglandin B.sub.2 or with oligomeric derivatives of prostaglandin B.sub.2, as well as to methods of

Antibiotic F-0769, process for its production, and its use as a growth accelerating and feed efficiency increasing agent and as an antitumour agent

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

The present invention relates to a novel antibiotic F-0769, a process for its production, and its use as a growth accelerating and feed efficiency increasing agent for domestic animals or fowls and as an antitumour agent. The present inventors have isolated a number of microorganisms from various

Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

CROSS-REFERENCE TO RELATED APPLICATION This application claims priority of U.S. provisional patent application No. 61/348,764 filed on May 27, 2010 the disclosure of which is incorporated by reference. TECHNICAL FIELD The present invention relates to a method for the preparation of a

Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD The present invention relates to a method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the composition made by the process. The present invention also relates to the use of the high-temperature stable oxygen

Imidazo[1,2 a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION This invention relates to the manufacture of novel chemical compounds which have biological activity, particularly to novel chemical compounds that are cytotoxic against colon cancer cells and colon cancer cell lines. BACKGROUND OF THE INVENTION Cancer is considered to be the

Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

CROSS-REFERENCE TO RELATED APPLICATIONS The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/US2012/042254 filed Jun. 13, 2012, which claims the benefit of priority of a continuation-in-part application Ser. No. 12/009,649 filed 22 Jan.

Agent for the treatment of alopecia

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD The present invention relates to an agent for the treatment and/or prevention of alopecia, dandruff, white hair, and seborrheic scalp, the agent containing as an active ingredient an A-type natriuretic peptide (ANP), a B-type natriuretic peptide (BNP), a C-type natriuretic peptide

Method for treating alopecia with B-type natriuretic peptide

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Glycoproteins and processes for their production

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to novel glycoproteins obtained from an extract or a supernatant of culture medium of reticulo-endothelial cells, lymphoblasts, leukemia cells or fibroblasts of warm-blooded animals, processes for their production and

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa